Zumwalt et al. compared the effect of aspirin on various colon carcinoma cell lines and found that aspirin treatment of PIK3CA-mutant colon cancer cells leads to a downregulation of cell-cycle-related genes and reduced tumor growth in mouse xenografts [33]. This evidence concerns the gene PIK3CA and colon carcinoma.